Hero-Approach

Today’s news. Tomorrow’s story.

News

News articles by MTIP

MTIP's new investment in Trialbee
28/04/2020
MTIP's new investment in Trialbee

Investment led by MTIP enables the Trialbee to meet the growing demand for patient-centric technology solutions in clinical trials
TytoCare closes $50 million round as the demand for telehealth accelerates
09/04/2020
TytoCare closes $50 million round as the demand for telehealth accelerates

The $50 million round will support the Company to continue to scale business activities globally, as well as respond to the increase in demand for their digital health solutions.
The digital healthtech sector is expanding – and so are we!
07/04/2020
The digital healthtech sector is expanding – and so are we!

MTIP welcomes in April Christoph Mårtensson as Investment Associate and Jessica Di Palo as Head of Marketing and Communications!
MTIP has sucessfully exited Blueprint Genetics
22/01/2020
MTIP has sucessfully exited Blueprint Genetics

MTIP has successfully exited Blueprint Genetics to Quest Diagnostics. Together, Quest Diagnostics, the world’s leading provider of diagnostic information services, and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development. Financial terms of the transaction were not disclosed.

Press and media articles

Your Contact Person

MTIP Jessica Di Palo

Jessica Di Palo

Head of Marketing and Communications

communications@mtip.ch